Clinical Trial Update: Nalrexone Facilitated Discontinuation of Buprenorphine [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating nalrexone-facilitated discontinuation of buprenorphine in individuals with stable opioid dependence has completed, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Dependence

Drugs mentioned

• Nalrexone (nalrexone)
• buprenorphine (buprenorphine)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Stable Opioid Dependence | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-09-06